Thus, the LDH-B/LDH-A ratio could be a biomarker of tumor aggressiveness, particularly as it relates to breast cancer subtypes in TNBCs, particularly the luminal versus basal-like subtypes, which have different prognoses [41]. This evidence concerns the gene LDHB and neoplasm.